Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
SwiftConnect Raises $37 Million of Financing in Series B Round
Life Sciences Times
-
November 14, 2024
0
Venture Capital
SAI MedPartners Expands Strategic Service Offering Through Acquisition of IDEA Pharma
Life Sciences Times
-
November 14, 2024
0
Medtech
Predictive Heart Monitoring Startup, GPx, Secures New Investment From NEC X; Joins Elev X! Boost Venture Studio Program
Life Sciences Times
-
November 13, 2024
0
Venture Capital
Metsera Secures $215 Million Series B Financing to Further Accelerate Portfolio
Life Sciences Times
-
November 13, 2024
0
Venture Capital
TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development
Life Sciences Times
-
November 13, 2024
0
Venture Capital
Bureau Veritas Continues to Build Capabilities in the Energy and Renewables Sector Through the Acquisition of Versatec Energy B.V.
Life Sciences Times
-
November 12, 2024
0
Venture Capital
Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors
Life Sciences Times
-
November 7, 2024
0
Biotech
DirectSens’ Market-Leading LactoSens® Biosensor Technology Acquired by Kerry Group P.L.C.
Life Sciences Times
-
November 5, 2024
0
Venture Capital
Ecolab Acquires Barclay Water Management
Life Sciences Times
-
November 5, 2024
0
Venture Capital
CrossBridge Bio Secures $10 Million Financing to Advance the Development of Next-Generation Dual-Payload ADC Therapies
Life Sciences Times
-
November 4, 2024
0
Venture Capital
Pagaya Completes Acquisition of Theorem Technology, Inc.
Life Sciences Times
-
October 28, 2024
0
Venture Capital
Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates
Life Sciences Times
-
October 28, 2024
0
1
...
23
24
25
...
115
Page 24 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026